aTyr Pharma, Inc.

NASDAQ:ATYR

Biotechnology

Healthcare
$0.53 +14.23%

+$0.07 today

Market cap
$52.13M
Beta
0.54
P/E (TTM)
-0.7
EPS (TTM)
-$0.71
52W Low $0.40High $7.29

Volume 1.02M

Average 2.29M

Balance Sheet

Inspect the capital base behind the business.

Assets

$94.16M

FY 2025 · Annual

-2.8% YoY

Liabilities

$26.88M

FY 2025 · Annual

-0.5% YoY

Equity

$67.29M

FY 2025 · Annual

-3.6% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents2.34M9.98M22.54M11.06M10.74M
Short-term Investments105.58M56.17M75.62M61.07M67.94M
Net Receivables435K11.78M2.44M1.74M873K
Inventory00000
Other Current Assets00000
Total Current Assets113.57M80.87M102.99M81.95M80.24M
Property, Plant & Equipment (Net)1.81M11.56M14.05M11.86M10.38M
Goodwill00000
Intangible Assets00000
Long-term Investments00002.24M
Tax Assets00000
Other Non-current Assets158K3.36M3.62M3.02M1.31M
Total Non-current Assets1.97M14.92M17.66M14.88M13.93M
Total Assets115.54M95.79M120.65M96.83M94.16M
Account Payables1.03M3.11M3.53M4.32M3.89M
Short-term Debt00001.47M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities00006.81M
Total Current Liabilities6.01M13.86M16.42M14.97M15.15M
Long-term Debt00000
Deferred Tax Liabilities00001.16M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities398K10.64M13.77M12.03M11.73M
Total Liabilities6.41M24.5M30.18M27M26.88M
Common Stock28K29K63K84K98K
Retained Earnings(372.3M)(417.63M)(468.02M)(532.05M)(606.16M)
Accumulated OCI(263K)(433K)(74K)(40K)(8K)
Other Stockholders Equity00000
Minority Interest(175K)(180K)(188K)(187K)(192K)
Total Equity109.13M71.28M90.47M69.83M67.29M
Total Debt1.38M11.53M15.1M13.28M12.03M
Net Debt(958K)1.55M(7.45M)2.23M1.29M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$10.0M
Short-term Investments$56.5M
Receivables$477.0K
Other Current$586.0K
Total Current Assets$67.6M
PP&E (Net)$10.1M
Long-term Investments$1.8M
Other Non-current$148.0K
Total Non-current Assets$12.1M
Total Assets$79.7M

Analysis

Selected assets total $79.7M for Latest. The largest visible component is Short-term Investments at $56.5M, about 70.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
S-8S-8 filingAug 7, 2026
8-KCurrent reportAug 7, 2026
10-QQuarterly reportAug 7, 2026
SC 13G/ASC 13G/A filingAug 6, 2026
8-KCurrent reportJul 31, 2026

How much cash does ATYR have?

aTyr Pharma, Inc. (ATYR) reported $10.74M in cash and equivalents in fiscal 2025.

How much debt does ATYR carry?

aTyr Pharma, Inc. (ATYR) reported $12.03M of total debt, with net debt of $1.29M.